IQDNX & IQDAX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Infinity Q Diversified Alpha Fund Institutional & Investor Class of Class Action and Lead Plaintiff Deadline: April 27, 2021
April 21, 2021 10:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Infinity Q...
Form 8.3 - Aggreko Plc
April 21, 2021 09:59 ET
|
Rathbone Brothers Plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)AMENDMENT CHANGE TO...
Achieve3000 Tackles Barriers From High School to HBCUs
April 21, 2021 09:59 ET
|
Achieve3000
Red Bank, NJ, April 21, 2021 (GLOBE NEWSWIRE) -- Achieve3000, the leader in learning acceleration for PreK-12 students, has partnered with national thought leaders from public K-12 school districts,...
Global Tissue Engineered Skin Substitutes Market to Reach $909 Million by 2027
April 21, 2021 09:57 ET
|
ReportLinker
New York, April 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Engineered Skin Substitutes Industry" -...
Health Insurance Market Size [2021-2028] | Is set to reach USD 3,038.6 Billion and Exhibit a CAGR of 5.5% by 2028
April 21, 2021 09:54 ET
|
Fortune Business Insights
Pune, India, April 21, 2021 (GLOBE NEWSWIRE) -- The global “health insurance market” size is set to reach USD 3,038.6 billion by 2028. Fortune Business Insights™ presented this information in a new...
Global Tissue Engineering Market to Reach $26.8 Billion by 2027
April 21, 2021 09:52 ET
|
ReportLinker
New York, April 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Engineering Industry" - https://www.reportlinker.com/p06033135/?utm_source=GNW 8...
Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide
April 21, 2021 09:52 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 21 April 2021 – Novo Nordisk today announced the decision to enter phase 3a development in obesity with oral semaglutide 50 mg. The decision follows the completion of the STEP phase...
Marknadsuppdatering : Ellen AB levererar ett förbättrat resultat för de tre första månaderna 2021
April 21, 2021 09:50 ET
|
Ellen AB
Ellens nettoomsättning uppgick till 5 549 (5 981) KSEK första kvartalet vilket är -7,2 procent jämfört mot föregående år som var ”all time high” med en tillväxt på +36%. Ellen redovisar en oförändrad...
Global BFSI Security Market to Generate $114.498 Billion by 2027: Says AMR
April 21, 2021 09:50 ET
|
Allied Market Research
Portland.OR, April 21, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global BFSI security market garnered $42.73 billion in 2019, and is estimated to...
Global Tissue Expanders Market to Reach $1.5 Billion by 2027
April 21, 2021 09:47 ET
|
ReportLinker
New York, April 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Expanders Industry" - https://www.reportlinker.com/p06033136/?utm_source=GNW 5...